Enzyme Replacement Therapy Market Reaping US$ 13,776.2 Mn by 2028
Increase in healthcare expenditure and prevalence of rare diseases are among prime factors driving the ERT market. Growth in the demand for ERT to improve the treatment of rare diseases is anticipated to drive the market over the forecast period.
View full press release